Hepatitis C

Anaesthesia and Intensive Care

Volumn 24, Issue 2, 1996, Pages 180-183

  Liddle, C ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b University of Sydney   (Australia)

Author keywords

Liver: viral hepatitis, hepatitis C, liver disease

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS C ANTIBODY; INTERFERON;

ANTIBODY TITER; AUSTRALIA; BLOOD; CONFERENCE PAPER; ETHNOLOGY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; MOLECULAR CLONING; NEEDLESTICK INJURY; OCCUPATIONAL HAZARD; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; TATTOO; VERTICAL TRANSMISSION; VIRUS GENOME;

EID: 0029965408     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9602400209     Document Type: Conference Paper

References (37)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-362.
2. Houghton M, Weiner A, Kho G, Choo Q-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14:381-388.
3. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19:1321-1324.
4. McCaughan GW, McGuinness PH, Bishop GA, et al. Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors. Med J Aust 1992; 157:231-233.
5. Allain JP, Coghlan PJ, Kenrick KG, et al. Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNA. Blood 1991; 78:2462-2468.
6. Lam JP, McOmish F, Burns SM, Yap PL, Mok Y, Simmonds P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993; 167:572-576.
7. Meisel H, Reip A, Faltus B, Lu M, Porst H, Wiese M, Roggendorf M, Kruger DH. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet 1995; 345:1209-1211.
8. Wang Y, Tao QM, Zhao HY, et al. Hepatitis C virus RNA and antibodies among blood donors in Beijing. J Hepatol 1994; 21:634-640.
9. Bell J, Batey RG, Farrell GC, Crewe EB, Cunningham AL, Byth K. Hepatitis C virus in intravenous drug users. Med J Aust 1990; 153:274-276.
10. Wang YJ, Lee SD, Hwang SJ, Chan CY, Chow MP, Lai ST, Lo KJ. Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody. Vox Sang 1994; 67: 187-190.
11. Alter HJ. Transfusion transmitted hepatitis C and non-A, non-B, non-C. Vox Sang 1994; 67 Suppl 3:19-24.
12. Kaldor JM, Archer GT, Buring ML, et al. Risk factors for hepatitis C infection in blood donors: a case-control study. Med J Aust 1992; 157:227-230.
13. Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV, Quinn TC. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore - an analysis of 309 sex partnerships. J Infect Dis 1995; 171:768-775.
14. Manzini P, Saracco G, Cerchier A, et al. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology 1995; 21:328-332.
15. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 1995; 345:289-291.
16. Hallam NF, Fletcher ML, Read SJ, Majid AM, Kurtz JB, Rizza CR. Low risk of sexual transmission of hepatitis C virus. J Med Virol 1993; 40:251-253.
17. Lanphear BP, Linnemann CC, Cannon CG, DeRonde MM, Pendy L, Kerley LM. Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol 1994; 15:745-750.
18. Goetz AM, Ndimbie OK, Wagener MM, Muder RR. Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center. Transplantation 1995; 59:990-994.
19. Garcia-Bengoechea M, Emparanza JI, Sarriugarte A, Cortes A, Vega JL, Gonzalez F, Arenas JI. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. Eur J Gastroenterol Hepatol 1995; 7:237-241.
20. Allander T, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345:603-607.
21. Dussol B, Berthezene P, Brunet P, Roubicek C, Berland Y. Hepatitis C virus infection among chronic dialysis patients in the south of France: a collaborative study. Am J Kidney Dis 1995; 25:399-404.
22. Chant K, Kociuba K, Munro R, et al. Investigation of possible patient-to-patient transmission of hepatitis C in a hospital. NSW Public Health Bull 1994; 5:47-51.
23. Wang JT, Wang TH, Lin JT, Sheu JC, Lee CZ, Chen DS. Improved serodiagnosis of posttransfusion hepatitis C virus infection by second-generation immunoassay based on multiple recombinant antigens. Vox Sang 1992; 62:21-24.
24. Aranha GV, Sontag SJ, Greenlee HB. Cholecystectomy in cirrhotic patients: a formidable operation. Am J Surg 1982; 143:55-60.
25. Garrison RN, Cryer HM, Howard DA, Polk HC. Classification of risk factors for abdominal surgery in patients with hepatic cirrhosis. Ann Surg 1984; 199:648-655.
26. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327:1906-1911.
27. Blum HE. Does hepatitis C virus cause hepatocellular carcinoma? Hepatology 1994; 19:251-258.
28. Weltman M, Brotodiharjo A, Farrell GC, Liddle C. Coinfection with hepatitis B and C or B, C and D viruses: patient characteristics, severity of liver disease and response to interferon treatment. J Viral Hepatitis 1995; 2:39-45.
29. Shindo M., Di Bisceglie A.M., Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with α-interferon. Hepatology 1992; 15:1013-1016.
30. Reichard O, Foberg U, Fryden A. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks. Hepatology 1994; 19:280-285.
31. Jouet P, Roudot-Thoraval F, Dhumeaux D, Metreau JM. Comparative efficacy of interferon alfa in cirrhotic and non-cirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Francais pour l'Etude du Traitement des Hepatites Chroniques NANB/C. Gastroenterology 1994; 106:686-690.
32. Lin R, Schoeman MN, Craig PI, et al. Can the response to interferon treatment be predicted in patients with chronic active hepatitis C? Aust NZ J Med 1991; 21:387-392.
33. Tsubota A, Chayama K, Ikeda K. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994; 19:1088-1094.
34. Lau JY, Davis GL Kniffen J. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341:1501-1504.
35. Brillanti S, Garson J, Foli M, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994; 107:812-817.
36. Marzano A, Smedile A, Abate M, et al. Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence. J Hepatol 1994; 21:961-965.
37. Sheiner PA, Schwartz ME, Mor E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21:30-34.